Gilead Targets Remdesivir Supply for Two Million Covid-19 Patients By Year-end
The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, currently administered only intravenously.
from Top World News- News18.com https://ift.tt/2CrHJsd
No comments:
Post a Comment